# Celldex Therapeutics, Inc.: Form 8-K, filed Apr 3, 2012

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: 8-K
- Filed: 2012-04-03
- Accepted by EDGAR: Apr 3, 2012, 16:30 ET
- Period: 2012-03-29
- Accession: 0001104659-12-023622
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000110465912023622/a12-9040_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000110465912023622/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000110465912023622/a12-9040_18k.htm

Filed Apr 3, 2012.
Source: SEC EDGAR, the filing index for accession 0001104659-12-023622. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.
